当前位置: 首页 > 期刊 > 《中外医疗》 > 20207
编号:13498128
基于CRISPR/Cas9构建小鼠UOX基因敲除模型(4)
http://www.100md.com 2020年3月5日 《中外医疗》 20207
     [8] 廖鹏飞,聂旺,余雅心,等.ZFNs、TALENs和CRISPR-Cas基因组靶向编辑技术及其在植物中的应用[J].基因组学与应用生物学,2016,35(2):442-451.

    [9] Tu z,Yang W,Yan S,et al.CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases[J]. Molecular Neurodegeneration, 2015, 10(1):35.

    [10] Roper J ,Tammela T , Akkad A , et al. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation[J].Nature Protocols, 2018, 13(2):217-234.

    [11] Dow L E, Fisher J, O'Rourke K P, et al. Inducible in vivo genome editing with CRISPR/Cas9[J].Nature Biotechnology, 2015, 33(4):390-394.

    [12] Hosoyamada M, Tsurumi Y, Hirano H, et al. Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury[J]. Nucleosides Nucleotides Nucleic Acids, 2016, 35(10-12):543-549.

    [13] 樓秀余. 人类痛风病与UOX基因沉默相关的研究[J]. 中外医学研究, 2012(29):154-155.

    [14] Dow, Lukas E . Modeling Disease In Vivo With CRISPR/Cas9[J]. Trends in Molecular Medicine, 2015, 21(10):609-621.

    (收稿日期:2019-12-05), http://www.100md.com(张茹君 夏海林 朱赟 黄晶 孟雨菡)
上一页1 2 3 4